What does CUSIP 09073Q204 represent in this 13F holders report?

CUSIP 09073Q204 is the security identifier for SCNI - SCINAI IMMUNOTHERAPEUTICS LT - SPON ADS NEW used to aggregate holder disclosures.

How many institutions held SCNI - SCINAI IMMUNOTHERAPEUTICS LT - SPON ADS NEW in Q4 2022?

9 institutional investors reported SCNI - SCINAI IMMUNOTHERAPEUTICS LT - SPON ADS NEW for Q4 2022. Use the holders table for investor-level position and value details.

SCINAI IMMUNOTHERAPEUTICS LT - SPON ADS NEW (SCNI)

CUSIP: 09073Q204

Q4 2022 13F Holders as of 31 Dec 2022

Security type / class: Equity / SPON ADS NEW
Total 13F shares: 241,795
Total 13F value: $715,888
Share change: +241,795
SEC-reported price per share: $2.96
Number of holders: 9
Value change: +$715,888
Number of buys: 9

Security key

09073Q204

Report period

Q4 2022

Institutions

Top holders

SCNI full security history Ownership snapshot Full 13F holder table Scinai Immunotherapeutics Ltd. SEC filings Scinai Immunotherapeutics Ltd. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of SCNI - SCINAI IMMUNOTHERAPEUTICS LT - SPON ADS NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

ENVESTNET ASSET MANAGEMEN...

Disclosed value leader

ENVESTNET ASSET MANAGEMEN...

Comparable rows

0/10

Latest evidence

30 Sep 2022

13F Highest disclosed value: $58,000 10 rows are not safely comparable across share classes. Showing 1-6 of 10 holder rows.

Quick read

ENVESTNET ASSET MANAGEMENT INC has the largest disclosed position value at $58K.

0 of 10 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ENVESTNET ASSET MANAGEMENT INC's linked filing trail.

Disclosed position value Top 5

ENVESTNET ASSET MANAGEMENT INC $58K

TRUE Private Wealth Advisors $34K

MORGAN STANLEY $17K

RENAISSANCE TECHNOLOGIES LLC $13K

GEODE CAPITAL MANAGEMENT, LLC $10K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 10 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
ENVESTNET ASSET MANAGEMENT INC	13F Company 13F	— denominator unverified	$58,000 79,216 shares	—	30 Sep 2022
TRUE Private Wealth Advisors	13F Company 13F	— denominator unverified	$34,000 47,000 shares	—	30 Sep 2022
MORGAN STANLEY	13F Company 13F	— denominator unverified	$17,000 22,590 shares	—	30 Sep 2022
RENAISSANCE TECHNOLOGIES LLC	13F Company 13F	— denominator unverified	$13,000 18,400 shares	—	30 Sep 2022
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	— denominator unverified	$10,000 13,768 shares	—	30 Sep 2022
MILLENNIUM MANAGEMENT LLC	13F Company 13F	— denominator unverified	$9,000 12,275 shares	—	30 Sep 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

241,795

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders

Q4 2022 holders

Holder diff

Investor	Q3 2022 Shares	Q4 2022 Shares	Share Diff	Share Chg %	Q3 2022 value	Q4 2022 value	Value change	Value Chg %